Acumapimod (BCT-197)
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 319515

CAS#: 836683-15-9

Description: Acumapimod, also known as BCT-197, is a potent P38 mitogen-activated protein kinase inhibitor. The p38 protein kinases, in particular p38α and p38β, regulate the production of multiple inflammatory mediators.

Chemical Structure

img
Acumapimod (BCT-197)
CAS# 836683-15-9
Product data Instruction

Theoretical Analysis

MedKoo Cat#: 319515
Name: Acumapimod (BCT-197)
CAS#: 836683-15-9
Chemical Formula: C22H19N5O2
Exact Mass: 385.15
Molecular Weight: 385.427
Elemental Analysis: C, 68.56; H, 4.97; N, 18.17; O, 8.30

Price and Availability

Size Price Availability Quantity
10mg USD 110 Ready to ship
25mg USD 220 Ready to ship
50mg USD 385 Ready to ship
100mg USD 685 Ready to ship
200mg USD 1150 Ready to ship
500mg USD 2450 Ready to ship
Bulk inquiry

Synonym: BCT-197; BCT197; BCT 197; BCT197A2201; Acumapimod

IUPAC/Chemical Name: 3-(5-amino-4-(3-cyanobenzoyl)-1H-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide

InChi Key: VGUSQKZDZHAAEE-UHFFFAOYSA-N

InChi Code: InChI=1S/C22H19N5O2/c1-13-5-6-16(22(29)26-17-7-8-17)10-19(13)27-21(24)18(12-25-27)20(28)15-4-2-3-14(9-15)11-23/h2-6,9-10,12,17H,7-8,24H2,1H3,(H,26,29)

SMILES Code: O=C(NC1CC1)C2=CC=C(C)C(N3N=CC(C(C4=CC=CC(C#N)=C4)=O)=C3N)=C2

Appearance: Yellow to orange solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target: Acumapimod (BCT197) is a p38 MAP kinase inhibitor, with an IC50 of less than 1 μM for p38α.
In vitro activity: N/A
In vivo activity: All vehicle-treated animals were removed from study and euthanized by day 9 due to ≥25 % body weight loss (Fig. 2). Compared to vehicle, a protective effect was observed with 31 % (5/16) of the 6 mg kg−1 BCT197, 67 % (10/15) dexamethasone and 94 % (15/16) oseltamivir-treated animals surviving to the end of study. However, only 12.5 % (2/16) survival was observed in the 18 mg kg−1 BCT197 group (Fig. 2b). All of the curves were statistically significantly different from vehicle (P<0.0125, using Bonferroni correction for multiple comparisons as part of the Kaplan–Meier analysis). Reference: J Med Microbiol. 2018 Mar;67(3):452-462. https://pubmed.ncbi.nlm.nih.gov/29458547/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 50.0 129.73

Preparing Stock Solutions

The following data is based on the product molecular weight 385.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Growcott EJ, Bamba D, Galarneau JR, Leonard VHJ, Schul W, Stein D, Osborne CS. The effect of P38 MAP kinase inhibition in a mouse model of influenza. J Med Microbiol. 2018 Mar;67(3):452-462. doi: 10.1099/jmm.0.000684. Epub 2018 Jan 24. PMID: 29458547. 2. Parkin JM, Hardaker EL. Effects of Acumapimod (PCT197), an Oral p38 Inhibitor, on Tobacco Smoke and Lipopolysaccharide-Induced Lung Inflammation in a Corticosteroid-Resistant Rat Model. Am J Respir Crit Care Med. 2017 May;195:A6305.
In vitro protocol: N/A
In vivo protocol: 1. Growcott EJ, Bamba D, Galarneau JR, Leonard VHJ, Schul W, Stein D, Osborne CS. The effect of P38 MAP kinase inhibition in a mouse model of influenza. J Med Microbiol. 2018 Mar;67(3):452-462. doi: 10.1099/jmm.0.000684. Epub 2018 Jan 24. PMID: 29458547. 2. Parkin JM, Hardaker EL. Effects of Acumapimod (PCT197), an Oral p38 Inhibitor, on Tobacco Smoke and Lipopolysaccharide-Induced Lung Inflammation in a Corticosteroid-Resistant Rat Model. Am J Respir Crit Care Med. 2017 May;195:A6305.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Agyemang A, Farrell C, Moore W, Parkin J. A Physiologically Based Pharmacokinetic Model to Predict Potential Drug-Drug Interactions and Inform Dosing of Acumapimod, an Oral p38 MAPK Inhibitor. CPT Pharmacometrics Syst Pharmacol. 2021 Jan;10(1):30-39. doi: 10.1002/psp4.12565. Epub 2020 Dec 30. PMID: 33107218; PMCID: PMC7825188.


2: Strâmbu IR, Kobalava ZD, Magnusson BP, MacKinnon A, Parkin JM. Phase II Study of Single/Repeated Doses of Acumapimod (BCT197) to Treat Acute Exacerbations of COPD. COPD. 2019 Dec;16(5-6):344-353. doi: 10.1080/15412555.2019.1682535. Epub 2019 Nov 4. PMID: 31682162.


3: Norman P. Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease. Expert Opin Investig Drugs. 2015 Mar;24(3):383-92. doi: 10.1517/13543784.2015.1006358. Epub 2015 Jan 20. PMID: 25599809.